Luminita C. Miclea

Mrs. Luminita C. Miclea

Carol Davila University of Medicine and Pharmacy, Bucharest, Bucureşti, Romania
+1

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DTDeculescu-Ionita teodora
Deculescu-Ionita teodora
OFOana Cezara Frasina-Vlad
Oana Cezara Frasina-Vlad
LMLuminita C. Miclea
Luminita C. Miclea
CGConstanta Ganea
Constanta Ganea
JSJános Szöllősi
János Szöllősi
MMMagda Mocanu
Magda Mocanu
The aim of the manuscript is to discuss the influence of plant polyphenols in overcoming multidrug resistance in four types of solid cancers (breast, colorectal, lung and prostate cancer). Effective treatment requires the use of multiple toxic chemotherapeutic drugs with different properties and targets. However, a major cause of cancer treatment failure and metastasis is the development of multidrug resistance. Potential mechanisms of multidrug resistance include increase of drug efflux, drug inactivation, detoxification mechanisms, modification of drug target, inhibition of cell death, involvement of cancer stem cells, dysregulation of miRNAs activity, epigenetic variations, imbalance of DNA damage/repair processes, tumor heterogeneity, tumor microenvironment, epithelial to mesenchymal transition and modulation of reactive oxygen species. Taking into consideration that synthetic multidrug resistance agents have failed to demonstrate significant survival benefits in patients with different types of cancer, recent research have focused on beneficial effects of natural compounds. Several phenolic compounds (flavones, phenolcarboxylic acids, ellagitannins, stilbens, lignans, curcumin, etc.) act as chemopreventive agents due to their antioxidant capacity, inhibition of proliferation, survival, angiogenesis, and metastasis, modulation of immune and inflammatory responses or inactivation of pro-carcinogens. Moreover, preclinical and clinical studies revealed that these compounds prevent multidrug resistance in cancer by modulating different pathways. Additional research is needed regarding the role of phenolic compounds in the prevention of multidrug resistance in different types of cancer.

18 May 2023 in Biomedical Optics Express
Verified
Journal Article
Closed access
MMMona Mihailescu
Mona Mihailescu
LMLuminita C. Miclea
Luminita C. Miclea
APAna M. Pleava
Ana M. Pleava
NTNicolae Tarba
Nicolae Tarba
ESEugen Nicolae Scarlat
Eugen Nicolae Scarlat
TSTudor Savopol
Tudor Savopol
We present a method that integrates the standard imaging tools for locating and detecting unlabeled nanoparticles (NPs) with computational tools for partitioning cell volumes and NPs counting within specified regions to evaluate their internal traffic. The method uses enhanced dark field CytoViva optical system and combines 3D reconstructions of double fluorescently labeled cells with hyperspectral images. The method allows the partitioning of each cell image into four regions: nucleus, cytoplasm, and two neighboring shells, as well as investigations across thin layers adjacent to the plasma membrane. MATLAB scripts were developed to process the images and to localize NPs in each region. Specific parameters were computed to assess the uptake efficiency: regional densities of NPs, flow densities, relative accumulation indices, and uptake ratios. The results of the method are in line with biochemical analyses. It was shown that a sort of saturation limit for intracellular NPs density is reached at high extracellular NPs concentrations. Higher NPs densities were found in the proximity of the plasma membranes. A decrease of the cell viability with increasing extracellular NPs concentration was observed and explained the negative correlation of the cell eccentricity with NPs number.

31 March 2022 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
Ana-Maria BrezoiuAna-Maria Brezoiu
Ana-Maria Brezoiu
APAna-Maria Prelipcean
Ana-Maria Prelipcean
LMLuminita C. Miclea
Luminita C. Miclea
MMMihaela Moisescu
Mihaela Moisescu
Mihaela DeaconuMihaela Deaconu
Mihaela Deaconu
Daniela Cristina BergerDaniela Cristina Berger
Daniela Cristina Berger
Irinotecan is an antineoplastic used for the treatment of different types of cancer and solid tumors (rectal, colon, ovarian and glioblastoma)